Visitation declined at SV which I think is further indication of the massive increase in casino capacity.
The SV VIP business collapsed versus PCP and is a shadow of its former glory.
On a normalised (for theoretical win rate) EBITDA basis SV declined versus the PCP.
One of the worst acquisitions conducted by an ASX company from my memory.
Aristo was the highlight for me. That business is firing up again. I would not be suprised if Aristo makes more than SV longer term. The Chinese are big punters.
Plus, it actually has a solid market position where multiple competing casinos can't just pop up next door.
The odds of China legalising gambling in the neighbouring province is also close to zero, unlike Thailand which seems inevitable, though still years before impact.
Balance sheet is no longer an issue which is another big positive. Remains to be seen if they elect to pay dividends and/or conduct a buy back.
- Forums
- ASX - By Stock
- DNA
- Ann: 1H FY24 Investor Presentation
Ann: 1H FY24 Investor Presentation, page-18
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DNA (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.53M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.2¢ | $1.76K | 55K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 75000 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 13000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 75000 | 0.033 |
3 | 183291 | 0.032 |
1 | 25000 | 0.031 |
4 | 858353 | 0.030 |
5 | 450740 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 13000 | 1 |
0.035 | 6986 | 1 |
0.037 | 597415 | 1 |
0.039 | 267868 | 4 |
0.040 | 900000 | 1 |
Last trade - 11.54am 28/06/2024 (20 minute delay) ? |
Featured News
DNA (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online